Biomedical Engineering Reference
In-Depth Information
[58]
Yang, J., Lin, Y., Guo, Z.
et al., The essential role of MEKK3 in TNF-induced
NF-kappaB activation,
Nat. Immunol.,
2, 620, 2001.
[59]
Huang, Q., Yang, J., Lin, Y.
et al., Differential regulation of interleukin 1 receptor
and Toll-like receptor signaling by MEKK3,
Nat. Immunol.,
5, 98, 2004.
[60]
Shim, J.H., Xiao, C., Paschal, A.E. et al., TAK1 but not TAB1 or TAB2, plays an
essential role in multiple signaling pathways
in vivo, Genes Dev.,
19, 2668, 2005.
[61]
Sato, S., Sanjo, H., Takeda, K.
et al., Essential function for the kinase TAK1 in innate
and adaptive immune responses,
Nat. Immunol.
, 2005.
[62]
Yang, J., Boerm, M., McCarty, M.
et al., MEKK3 is essential for early embryonic
cardiovascular development,
Nat. Genet.,
24, 309, 2000.
[63]
Blonska, M., You, Y., Geleziunas, R.
et al., Restoration of NF-kappaB activation by
tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting
protein-deficient cells,
Mol. Cell Biol.,
24, 10757, 2004.
[64]
Yamaguchi, K., Shirakabe, K., Shibuya, H.
et al., Identification of a member of the
MAPKKK family as a potential mediator of TGF-beta signal transduction,
Science,
270, 2008, 1995.
[65]
Sakurai, H., Shigemori, N., Hasegawa, K.
et al., TGF-beta-activated kinase 1 stimu-
lates NF-kappa B activation by an NF-kappaB-inducing kinase-independent mecha-
nism,
Biochem. Biophys. Res. Commun.,
243, 545, 1998.
[66]
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A.
et al., The kinase TAK1 can activate
the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway,
Nature,
398, 252, 1999.
[67]
Ishitani, T., Takaesu, G., Ninomiya-Tsuji, J.
et al., Role of the TAB2-related protein
TAB3 in IL-1 and TNF signaling,
Embo. J.,
22, 6277, 2003.
[68]
Cheung, P.C., Nebreda, A.R., and Cohen, P., TAB3, a new binding partner of the
protein kinase TAK1,
Biochem. J.,
378, 27, 2004.
[69]
Sanjo, H., Takeda, K., Tsujimura, T.
et al., TAB2 is essential for prevention of
apoptosis in fetal liver but not for interleukin-1 signaling,
Mol. Cell Biol.,
23, 1231,
2003.
[70]
Komatsu, Y., Shibuya, H., Takeda, N.
et al., Targeted disruption of the Tab1 gene
causes embryonic lethality and defects in cardiovascular and lung morphogenesis,
Mech. Dev.,
119, 239, 2002.
[71]
Kanayama, A., Seth, R.B., Sun, L.
et al., TAB2 and TAB3 activate the NF-kappaB
pathway through binding to polyubiquitin chains,
Mol. Cell,
15, 535, 2004.
[72]
Deng, L., Wang, C., Spencer, E.
et al., Activation of the IkappaB kinase complex by
TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique
polyubiquitin chain,
Cell,
103, 351, 2000.
[73]
Legler, D.F., Micheau, O., Doucey, M.A.
et al., Recruitment of TNF receptor 1 to
lipid rafts is essential for TNFalpha-mediated NF-kappaB activation,
Immunity,
18,
655, 2003.
[74]
Chen, Z.J., Ubiquitin signalling in the NF-kappaB pathway,
Nat. Cell Biol.,
7, 758,
2005.
[75]
Kobayashi, N., Kadono, Y., Naito, A.
et al., Segregation of TRAF6-mediated signaling
pathways clarifies its role in osteoclastogenesis,
Embo. J.,
20, 1271, 2001.
[76]
Kayagaki, N., Yan, M., Seshasayee, D.
et al., BAFF/BLyS receptor 3 binds the B cell
survival factor BAFF ligand through a discrete surface loop and promotes processing
of NF-kappaB2,
Immunity,
17, 515, 2002.
[77]
Claudio, E., Brown, K., Park, S.
et al., BAFF-induced NEMO-independent processing
of NF-kappaB2 in maturing B cells,
Nat. Immunol.,
3, 958, 2002.
